| CAS No. | 171230-55-0 |
| Molecular Formula | - |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including (4S)-Rhodium, tetrakis[μ-[methyl 2-oxo-1-(1-oxo-3-phenylpropyl)-4-imidazolidinecarboxylato-N3:O2]]di-, (Rh-Rh), stereoisomer.
CATO supplies (4S)-Rhodium, tetrakis[μ-[methyl 2-oxo-1-(1-oxo-3-phenylpropyl)-4-imidazolidinecarboxylato-N3:O2]]di-, (Rh-Rh), stereoisomer (CAS 171230-55-0), a certified reference material (molecular formula N/A, MW N/A g/mol) for analytical method development and quality control.
(4S)-Rhodium, tetrakis[μ-[methyl 2-oxo-1-(1-oxo-3-phenylpropyl)-4-imidazolidinecarboxylato-N3:O2]]di-, (Rh-Rh), stereoisomer is supplied as a fully characterized reference material; its structural identity, assigned purity, and stability data are documented in the batch-specific Certificate of Analysis (COA).
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
CATO manufactures (4S)-Rhodium, tetrakis[μ-[methyl 2-oxo-1-(1-oxo-3-phenylpropyl)-4-imidazolidinecarboxylato-N3:O2]]di-, (Rh-Rh), stereoisomer under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Purity | 97%+ |
| Storage | Store at 2-8°C |
| Solubility (reference) | Freely soluble in water |
| Stability | Stable under recommended storage conditions |
| CAS Registry Year (est.) | 2005 |